Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -544 | -2,985 | -1,949 | -1,240 | -623 |
| Depreciation Amortization | 44 | 168 | 125 | 82 | 40 |
| Accounts receivable | 243 | 783 | -162 | -368 | -113 |
| Accounts payable and accrued liabilities | 188 | -1,384 | -1,228 | -113 | -318 |
| Other Working Capital | 176 | 12 | -1,139 | -423 | -311 |
| Other Operating Activity | -255 | 1,567 | 1,552 | 500 | 500 |
| Operating Cash Flow | $-148 | $-1,838 | $-2,799 | $-1,562 | $-824 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -37 | -36 | -31 | -9 |
| Purchase Of Investment | N/A | -9 | -9 | N/A | N/A |
| Sale Of Investment | N/A | 1,032 | 1,021 | N/A | N/A |
| Other Investing Activity | -14 | -41 | -25 | -14 | -7 |
| Investing Cash Flow | $-14 | $945 | $951 | $-44 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -21 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 267 | N/A | N/A | N/A |
| Other Financing Activity | 81 | 32 | 32 | -2 | -1 |
| Financing Cash Flow | $60 | $299 | $32 | $-2 | $-1 |
| Exchange Rate Effect | 14 | 194 | 287 | 258 | 43 |
| Beginning Cash Position | 2,486 | 2,887 | 2,887 | 2,887 | 2,887 |
| End Cash Position | 2,398 | 2,486 | 1,357 | 1,537 | 2,089 |
| Net Cash Flow | $-88 | $-401 | $-1,530 | $-1,350 | $-798 |
| Free Cash Flow | |||||
| Operating Cash Flow | -148 | -1,838 | -2,799 | -1,562 | -824 |
| Capital Expenditure | 0 | -37 | -36 | -31 | -9 |
| Free Cash Flow | -148 | -1,875 | -2,835 | -1,593 | -833 |